Revelation BioSciences
HOME CONTACT
PIPELINE CLINICAL TRIALS
News 2025 Annual Report Presentation ROTH 2026 WEBCAST CRRT Poster PRIME Data Stock Ticker SEC EDGAR
About Us Board of Directors Management Scientific Advisory Board Core Values
HOME PIPELINE & PROGRAMS PIPELINE CLINICAL TRIALS INVESTORS News 2025 Annual Report Presentation ROTH 2026 WEBCAST CRRT Poster PRIME Data Stock Ticker SEC EDGAR ABOUT US About Us Board of Directors Management Scientific Advisory Board Core Values CONTACT
Revelation BioSciences

News

Revelation Biosciences Inc. Receives TGA Acknowledgment to Start a Phase 1 Clinical Study of REVTx‑99 an Experimental Treatment for COVID‑19
James PhillipsOctober 7, 2020
Revelation Biosciences Inc. Receives Approval to Start a Phase 1 Clinical Study of REVTx‑99 an Experimental Treatment for COVID‑19
James PhillipsOctober 1, 2020
Newer
 
 
Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Subscribe

Sign up with your email address to receive news and updates.

Thank you!
 
Terms of UsePrivacy

© 2026 Revelation BioSciences